Ładuje się......
Alternative Facts and the ICER Proposed Policy on Access to Imaginary Pharmacoeconomic Worlds
The Institute for Clinical and Economic Review (ICER) announced at the end of March 2018 that it proposed to share executable draft economic models with relevant drug manufacturers during ICER evidence reviews. Taken at face value, ICER is offering manufacturers and other interested parties the poss...
Zapisane w:
| Wydane w: | Innov Pharm |
|---|---|
| 1. autor: | |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
University of Minnesota Libraries Publishing
2018
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6438559/ https://ncbi.nlm.nih.gov/pubmed/34007702 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.24926/iip.v9i2.1300 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|